oral solution articles & resources on Made-in-China.com

US FDA Has Approved Silvergate Pharmaceuticals' Epaned to Treat Hypertension

Aug 19, 2013

The US FDA has approved Silvergate Pharmaceuticals' Epaned (enalapril maleate Powder for Oral Solution) to treat hypertension (high blood pressure) in people aged one month and more. Silvergate Pharmaceuticals president and CEO Frank ...

Tags: Hypertension, Silvergate Pharmaceuticals'Epaned

Pharmaceutical Signed a Deal to Acquire Certain Assets of Pernix Therapeutics' Subsidiary

Aug 13, 2013

Pharmaceutical marketing, research and development company Breckenridge Pharmaceutical has signed a deal to acquire certain assets of Pernix Therapeutics' subsidiary, Cypress Pharmaceuticals, for $30m. The assets included in the agreement ...

Tags: Breckenridge, Cypress Pharmaceuticals

Tris Pharma Has Launched Dextroamphetamine Sulfate Oral Solution

Jul 12, 2013

Specialty pharmaceutical company Tris Pharma's generic pharmaceuticals business has launched Dextroamphetamine Sulfate Oral Solution to treat attention deficit disorder with hyperactivity (ADHD) and narcolepsy in the US. Available through ...

Tags: Tris Pharma, Medicine

Mission Pharmacal Company Has Introduced New Phosphate Oral Solution 25mg/5mL

Apr 2, 2013

Mission Pharmacal Company has introduced new flavored Prednisolone Sodium Phosphate Oral Solution 25mg/5mL for asthma patients in certain US markets. The company expects to make the flavored asthma medicine, with grape taste and higher ...

Tags: flavored oral asthma medicine, medicine, Pharmacal

Jazz Pharmaceuticals Has Received a US Patent for The Use of Xyrem Oral Solution

Dec 6, 2012

Jazz Pharmaceuticals has received a US patent for the use of Xyrem (sodium oxybate) oral solution in narcolepsy treatment. The new patent entitled Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate Salt for the ...

Tags: pharmaceuticals, US patent, sodium oxybate, narcolepsy

Perrigo Won Final FDA Approval for Its Abbreviated New Drug Application

Dec 5, 2012

Perrigo Company, a healthcare company, has won final FDA approval for its abbreviated new drug application for morphine sulfate 100ml/5% oral solution. Perrigo will immediately begin the shipment of Morphine sulfate oral solution, a ...

Tags: Perrigo Company, morphine sulfate, morphine sulfate oral solution

US Affiliate of Merz Pharma, Merz Has Acquired Cuvposa (Glycopyrrolate) Oral Solution

Dec 3, 2012

US affiliate of Merz Pharma, Merz has acquired Cuvposa (glycopyrrolate) oral solution, the only FDA approved treatment for pediatric chronic severe drooling (sialorrhea) associated with neurologic conditions such as cerebral palsy. ...

Tags: Merz Pharmaceuticals, CP, Cerebral palsy, Cuvposa

EffRx Has Launched a New Effervescent Buffered Oral Solution for Osteoporosis Treatment

Nov 28, 2012

EffRx Pharmaceuticals has launched a new effervescent buffered oral solution (70mg), designed for the treatment of osteoporosis, in the US. The new solution, BINOSTO (alendronate sodium), is intended for the treatment of osteoporosis in ...

Tags: oral solution, osteoporosis, alendronate sodium

Rising Pharmaceuticals Has Launched The Generic Version of Cleocin Pediatric

Nov 27, 2012

Rising Pharmaceuticals has launched the generic version of the 75mg/*5mL strength of Clindamycin Palmitate Hydrochloride for Oral Solution,USP(Pediatric). Clindamycin Palmitate Hydrochloride used to treat infections caused by bacteria,is ...

Tags: Rising Pharmaceuticals, Clindamycin Palmitate Hydrochloride

Sagent Has Launched Apnea of Prematurity Drug in Two Latex-Free Vial Presentations

Oct 4, 2012

Sagent Pharmaceuticals has launched Caffeine Citrate Injection, USP and Caffeine Citrate Oral Solution, USP, central nervous system stimulants, in two latex-free vial presentations. Caffeine Citrate Injection, USP and Caffeine Citrate ...

Tags: Drug, Medicine, Sagent Pharmaceuticals

Jazz Pharmaceuticals Announced The Issuance of New Formulation Patent for Xyrem

Sep 12, 2012

Jazz Pharmaceuticals, a specialty pharmaceutical company, has announced the issuance of new formulation patent for Xyrem (sodium oxybate) oral solution. Xyrem (sodium oxybate) oral solution is the FDA approved product for the ...

Tags: xyrem, cataplexy, patent, pharmaceutical product

oral solution

Related Products